beth israel deaconess medical center a harvard medical school teaching hospital

  • Contact BIDMC
  • Maps & Directions
  • Other Locations
  • Careers at BIDMC
  • Smaller Larger

Find a Doctor

Request an Appointment

Smaller Larger

Boston Marathon

Tread Strong

BIDMC is accepting applications for the 2017 Boston Marathon.
Visit to apply today!

2016 Boston Marathon

On April 18, 2016, Team BIDMC was represented by 52 runners in the 120th Boston Marathon. Team BIDMC raised more than $465,000—topping the previous year's total by more than $100,000—to benefit a variety of BIDMC causes ranging from community health programs to groundbreaking research. Our 2016 runners are supporting programs such as Kidney Disease Research, Bowdoin Street Healthy Champions Program, The Klarman Family Neonatal Intensive Care Unit (NICU), The Cancer Center, Cancer Vaccine Research, and the Annual Fund. Several of our runners are also supporting our Needham, Milton, and Plymouth affiliates.

For more information on the 2016 runners or to support Team BIDMC, visit Thank you for your support!

Boston Marathon 2016Bowdoin Street’s Healthy Champions Program

Healthy Champions is an interactive program at Bowdoin Street Health Center designed to create a way for economically disadvantaged young people to become ambassadors of health within their own families, schools, and the community.

Kidney Disease Research

Martin R. Pollak, M.D., and his team have identified a reason for the high rate of kidney disease in people of African descent and are actively working to alleviate this epidemic. Dr. Pollak and his team found that two common genetic variations in a gene called APOL1 are responsible for African Americans' greatly increased susceptibility to kidney disease - variations that likely become common because they protect against African sleeping sickness.

Cancer Vaccine Program

BIDMC’s Cancer Vaccine Program is one of the largest cancer vaccine and cellular immunotherapy programs throughout the world. David Avigan, M.D., and his colleagues develop personalized, patient-specific vaccines created from the patients’ own tumors and immune cells. Several hundred patients with blood cancers and solid tumors have been treated with vaccines generated in their clinical immunotherapy facility, and through these treatments Dr. Avigan has demonstrated that vaccination results in powerful anti-tumor immune responses.

Cancer Center

The Cancer Center at BIDMC is proud of its most gifted physicians and medical researchers who have made cancer treatment their life's work. Together with the outstanding nurses and staff, these dedicated professionals form a team that is committed to breakthrough treatments delivered with kindness and respect.  At the Cancer Center, scientists and doctors have made many discoveries that have led to greater understanding of cancer mechanisms resulting in improved and innovative cancer care. And because we have always understood the physical and emotional toll of a cancer diagnosis, our specialists take the time to listen to your concerns, answer your questions and develop unique support systems. Together, we can help you make the best decisions about your care and deliver treatment with unparalleled compassion.

Klarman Family Neonatal Intensive Care Unit

Each year, approximately one in eight babies in the United States is born prematurely, which has a profound impact on newborns and their families. These vulnerable babies often present with complex medical needs, ranging from severe breathing trouble to underdeveloped organs, and require specialized care to give them a healthy start. The Klarman Family Neonatal Intensive Care Unit (NICU) at BIDMC provides state-of-the-art, family-centered care for about 1,000 high-risk newborns and their families each year.

Annual Fund

The Annual Fund provides flexible funding to advance the priorities and projects that support our mission of providing unparalleled care for all of our patients, teaching the next generation of physicians, and finding cures for the most devastating diseases of our time.

John Hancock